Suven Pharmaceuticals renamed as Cohance Lifesciences

Suven Pharmaceuticals announced that the Ministry of Corporate Affairs, Government of India (MCA), has approved change of name of the Company from Suven Pharmaceuticals to Cohance Lifesciences, with effect from 07 May 2025. The change of name has been carried on pursuant to the Scheme of Amalgamation.

“The transition to Cohance Lifesciences marks a pivotal moment in our commitment to better serve our customers and their end market. We are building a global CDMO that aims to enable innovation across a broad range of modalities, chemistries, and technologies, to advance solutions for a healthier world ” said Cohance Executive Chairman, Vivek Sharma.

Related Posts

8 Women Develop Complications Post C-Section, 2 Critical

Close on the heels of maternal deaths and kidney-related complications reported in Kota and Bikaner following caesarean deliveries, a similar case has surfaced at Paota District Hospital in Jodhpur, where…

Kota District In-Charge Secretary Directs Implementation of Risk Management Framework in Hospitals; Emphasis on SOPs and Infection Control

Jaipur/Kota— In a significant move to strengthen patient safety and improve healthcare delivery in government hospitals, Kota district in-charge secretary Dr. Ravi Kumar Surpur has directed the immediate preparation and effective…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

8 Women Develop Complications Post C-Section, 2 Critical

8 Women Develop Complications Post C-Section, 2 Critical

Kota District In-Charge Secretary Directs Implementation of Risk Management Framework in Hospitals; Emphasis on SOPs and Infection Control

Kota District In-Charge Secretary Directs Implementation of Risk Management Framework in Hospitals; Emphasis on SOPs and Infection Control

Probe report into maternal deaths sparks Kota row

Probe report into maternal deaths sparks Kota row

Centre bans 16 Fixed-Dose Combination drugs over safety concerns

Centre bans 16 Fixed-Dose Combination drugs over safety concerns

Maha FDA seizes medicines worth Rs 9.09 lakh from Mumbai children’s hospital over alleged illegal sale

Maha FDA seizes medicines worth Rs 9.09 lakh from Mumbai children’s hospital over alleged illegal sale

CDSCO constitutes consultancy committee for advice on suo motu disclosure

CDSCO constitutes consultancy committee for advice on suo motu disclosure